scholarly journals Racial differences in blood pressure control rates in the VA medical center

2004 ◽  
Vol 17 (5) ◽  
pp. S203-S204
Author(s):  
S REHMAN
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Medical Center ◽  
Pressure Control

RACIAL DIFFERENCES IN BLOOD PRESSURE CONTROL RATES IN THE VA MEDICAL CENTER.

2004 ◽  
Vol 52 ◽  
pp. S280
Author(s):  
S U Rehman ◽  
B M Egan ◽  
F N Hutchison ◽  
Ralph H. V.A. Johnson
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Medical Center ◽  
Pressure Control

133 RACIAL DIFFERENCES IN BLOOD PRESSURE CONTROL RATES IN THE VA MEDICAL CENTER.

2004 ◽  
Vol 52 (Suppl 1) ◽  
pp. S280.4-S280
Author(s):  
S U Rehman ◽  
B M Egan ◽  
F N Hutchison ◽  
Ralph H. V.A. Johnson
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Medical Center ◽  
Pressure Control

scholarly journals Racial Differences in Blood Pressure Control: Potential Explanatory Factors

2008 ◽  
Vol 23 (5) ◽  
pp. 692-698 ◽  
Author(s):  
Hayden B. Bosworth ◽  
Benjamin Powers ◽  
Janet M. Grubber ◽  
Carolyn T. Thorpe ◽  
Maren K. Olsen ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Control Potential ◽  
Explanatory Factors

Racial differences in blood pressure control

Science ◽  
1979 ◽  
Vol 204 (4397) ◽  
pp. 1091-1094 ◽  
Author(s):  
A. Voors ◽  
G. Berenson ◽  
E. Dalferes ◽  
L. Webber ◽  
S. Shuler
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Pressure Control

Abstract MP64: Trends in Racial Differences in Control of Hypertension, 2008-2014

Circulation ◽  
2016 ◽  
Vol 133 (suppl_1) ◽  
Author(s):  
Kristi Reynolds ◽  
Zoë Bider ◽  
Corinna Koebnick ◽  
Michael Kanter ◽  
Joel Handler
Keyword(s):  
Blood Pressure ◽  
Health Care ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Health Care Delivery ◽  
Care Delivery ◽  
Patient Activation ◽  
Pressure Control ◽  
Health Care Delivery System ◽  
Hypertension Control

Background: Racial disparities in blood pressure control in the U.S. have been well documented. In 2010, Kaiser Permanente Southern California (KPSC), a large and diverse integrated health care delivery system that provides care to over 4 million members, implemented a series of changes in health care delivery to address the disparity in hypertension control. Key elements included changes to the care team, patient activation, meaningful use of health information technology, and leadership vision. Methods: We examined trends in hypertension control between 2008 and 2014 by race/ethnicity in KPSC members aged 18 years and older. Patients with hypertension were identified from the KPSC POINT® (Permanente Online Interactive Network Tool) population care management hypertension registry. Blood pressure control was defined according to JNC-7 criteria in the fourth quarter of each calendar year from 2008 through 2014. Results: Between 2008 and 2014, the hypertension population increased from 624,493 to 745,382, while the prevalence was stable (25.9% in 2008 and 25.6% in 2014). During this period, the proportion of Whites and Blacks decreased slightly from 45.4% to 43.0% and 14.3% to 13.5%, respectively, while the proportion of Hispanics and Asian/Pacific Islanders increased from 25.2% to 29.0% and 9.8% to 11.3%, respectively. Hypertension control increased from 74.0% in 2008 to 83.8% in 2014 and increased across age, sex, and racial/ethnic groups (Figure). Blacks had the largest improvement in hypertension control (68.8% to 80.8%), which was primarily driven by those aged 65+ years. The disparity in hypertension control between Whites and Blacks decreased from 6.9% to 5% between 2008 and 2014. Conclusions: While ecologic in nature, the secular increases in hypertension control suggest that implementation of a series of system-wide changes can affect all subpopulations.

Racial Differences in Blood Pressure Control: Potential Explanatory Factors

2006 ◽  
Vol 119 (1) ◽  
pp. 70.e9-70.e15 ◽  
Author(s):  
Hayden B. Bosworth ◽  
Tara Dudley ◽  
Maren K. Olsen ◽  
Corrine I. Voils ◽  
Benjamin Powers ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Control Potential ◽  
Explanatory Factors

scholarly journals Generic Medications and Blood Pressure Control in Diabetic Hypertensive Subjects: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study

Diabetes Care ◽  
2012 ◽  
Vol 36 (3) ◽  
pp. 591-597 ◽  
Author(s):  
D. M. Cummings ◽  
A. J. Letter ◽  
G. Howard ◽  
V. J. Howard ◽  
M. M. Safford ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Pressure Control ◽  
Generic Medications ◽  
Regards Study

Abstract P024: Blood Pressure Levels, Aggressiveness of Antihypertensive Therapy, and Prevalence of Left Ventricular Hypertrophy

Circulation ◽  
2015 ◽  
Vol 131 (suppl_1) ◽  
Author(s):  
Sindhu Lakkur ◽  
Sayed Soliman ◽  
Suzanne Oparil ◽  
Suzanne Judd ◽  
George Howard
Keyword(s):  
Blood Pressure ◽  
Left Ventricular Hypertrophy ◽  
Racial Differences ◽  
Blood Pressure Control ◽  
Antihypertensive Medication ◽  
Ventricular Hypertrophy ◽  
Pressure Control ◽  
Left Ventricular ◽  
Regards Study ◽  
Stage 1

A major cause of left ventricular hypertrophy (LVH) is an excessive hemodynamic load, making LVH more common among people with hypertension. Clinical trials of antihypertensive medication have found that treatment reduces left ventricular mass among those with hypertension, but little is known about the prevalence of LVH in the general population that are taking, and not taking, antihypertensive medication. We examined the cross-sectional association between blood pressure control and LVH among 28,106 participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, to test the hypotheses that: 1) within strata of blood pressure control, LVH will be more prevalent in those requiring more intensive treatment, and 2) that within strata of intensiveness of blood pressure treatment, that LVH will be more prevalent at higher blood pressure levels. The REGARDS study enrolled black and white participants, aged 45 and older, from 2003-2007. Systolic blood pressure was defined as normal (<120 mmHg), prehypertension (120 mmHg - 139 mmHg), stage 1 (140 mmHg - 159 mmHg), and stage 2 hypertension (>160 mmHg). Classes of antihypertensive medications at baseline were defined as 0, 1, 2, or 3 or more. LVH by electrocardiogram was detected in 2,803 participants. Multivariable-adjusted odds ratios (ORs) for LVH and 95% confidence intervals (CIs) were calculated using logistic regression models. The ORs (95% CIs) for each additional medication class were 1.31 (1.20-1.43) for normal blood pressure, 1.21 (1.14-1.27) for prehypertension, 1.07 (0.98-1.16) for stage 1, and 1.02 (0.88-1.17) for stage 2. The ORs (95% CIs) for each additional increase in blood pressure category were 1.57 (1.41-1.75) for no medications, 1.47 (1.33-1.63) for 1, 1.30 (1.18-1.43) for 2, and 1.21 (1.10-1.34) for 3 medications. We observed that successful blood pressure control by medication is still associated with elevated odds of LVH compared to untreated normotensive participants, emphasizing the importance of hypertension prevention.

Sign in / Sign up

Export Citation Format

Share Document